Danaher Corporation $DHR Shares Sold by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft lessened its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 28.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,045 shares of the conglomerate’s stock after selling 4,068 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Danaher were worth $1,904,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Enterprise Financial Services Corp grew its position in shares of Danaher by 1.4% in the 4th quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock valued at $737,000 after buying an additional 46 shares during the last quarter. Kennebec Savings Bank increased its position in shares of Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock worth $766,000 after purchasing an additional 46 shares in the last quarter. Revolve Wealth Partners LLC boosted its position in shares of Danaher by 2.6% in the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after purchasing an additional 47 shares during the period. High Note Wealth LLC grew its stake in Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares during the last quarter. Finally, First Command Advisory Services Inc. increased its position in Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after buying an additional 47 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 1.0%

NYSE DHR opened at $201.70 on Tuesday. The stock has a market capitalization of $142.76 billion, a P/E ratio of 39.01, a P/E/G ratio of 2.51 and a beta of 0.79. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a 50-day moving average price of $183.97 and a 200 day moving average price of $198.04. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.88 EPS. Equities research analysts expect that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analyst Ratings Changes

DHR has been the topic of a number of research reports. Wells Fargo & Company lowered their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Argus dropped their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Barclays decreased their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Evercore reiterated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Finally, Robert W. Baird dropped their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a report on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $231.64.

Get Our Latest Analysis on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.